Microneedle Arrays Allow Lower Microbial Penetration Than Hypodermic Needles In Vitro

R. F. Donnelly, T. R. R. Singh, M. M. Tunney, D. I. J. Morrow, Paul McCarron, C. O'Mahony, A. D. Woolfson

Research output: Contribution to journalArticlepeer-review

170 Citations (Scopus)

Abstract

In this study we determined, for the first time, the ability of microorganisms to traverse microneedle-induced holes using two different in vitro models. When employing SilescolA (R) membranes, the numbers of Candida albicans, Pseudomonas aeruginosa and Staphylococcus epidermidis crossing the membranes were an order of magnitude lower when the membranes were punctured by microneedles rather than a 21G hypodermic needle. Apart from the movement of C. albicans across hypodermic needle-punctured membranes, where 40.2% of the microbial load on control membranes permeated the barrier over 24 h, the numbers of permeating microorganisms was less than 5% of the original microbial load on control membranes. Experiments employing excised porcine skin and radiolabelled microorganisms showed that the numbers of microorganisms penetrating skin beyond the stratum corneum were approximately an order of magnitude greater than the numbers crossing SilescolA (R) membranes in the corresponding experiments. Approximately 10(3) cfu of each microorganism adhered to hypodermic needles during insertion. The numbers of microorganisms adhering to MN arrays were an order of magnitude higher in each case. We have shown here that microneedle puncture resulted in significantly less microbial penetration than did hypodermic needle puncture and that no microorganisms crossed the viable epidermis in microneedle-punctured skin, in contrast to needle-punctured skin. Given the antimicrobial properties of skin, it is, therefore, likely that application of microneedle arrays to skin in an appropriate manner would not cause either local or systemic infection in normal circumstances in immune-competent patients. In supporting widespread clinical use of microneedle-based delivery systems, appropriate animal studies are now needed to conclusively demonstrate this in vivo. Safety in patients will be enhanced by aseptic or sterile manufacture and by fabricating microneedles from self-disabling materials (e.g. dissolving or biodegradable polymers) to prevent inappropriate or accidental reuse.
Original languageEnglish
Pages (from-to)2513-2522
JournalPharmaceutical Research
Volume26
Issue number11
DOIs
Publication statusPublished (in print/issue) - 2009

Bibliographical note

PT: J; TC: 0

Fingerprint

Dive into the research topics of 'Microneedle Arrays Allow Lower Microbial Penetration Than Hypodermic Needles In Vitro'. Together they form a unique fingerprint.

Cite this